Health
Interferon treatment coupled with bone marrow transplant reduces risk of leukemia recurrence – News-Medical.Net
Researchers at the University of Michigan Health Rogel Cancer Center have identified a drug that, when given along with a bone…
Researchers at the University of Michigan Health Rogel Cancer Center have identified a drug that, when given along with a bone marrow transplant, drops the risk of leukemia recurring by 20% among the high-risk patients.
The study, published in Blood Advances,…
Continue Reading
-
Business16 hours ago10 ASX shares to buy after the market selloff
-
General20 hours ago‘We are here for you’: PM to bring help to flood zones
-
Business16 hours ago$10,000 invested in ANZ shares 5 years ago is now worth…
-
General18 hours agoWe’ve all talked about potential economic consequences for Australia of Trump’s policies. Now they’re happening